ARTV
Artiva Biotherapeutics, Inc.
Company overview
- Market capitalization
- $344.68M
- Employees
- 106
- Latest publication
- 2026-09-29
About Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. Its lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, and B-cell-non-Hodgkin lymphoma. The company also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 targeting chimeric antigen receptor (CAR)-NK cell product candidate for the treatment of various solid tumors, such as breast, gastric and esophageal, and bladder cancers; and AB-205, an allogeneic anti-CD5 CAR-NK cell product candidate for the treatment of hematological malignancies. Artiva Biotherapeutics, Inc. was incorporated in 2019 and is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 251,000USD |
| Cost Of Revenue | 666,000USD | 666,000USD | 662,000USD | — | — | — | — | — |
| Gross Profit | -666,000USD | -666,000USD | -662,000USD | — | — | — | — | 251,000USD |
| Research Development | 19,312,000USD | 16,994,000USD | 17,633,000USD | 17,861,000USD | 17,052,000USD | 13,317,000USD | 13,524,000USD | 11,156,000USD |
| Selling General Administrative | 5,118,000USD | 4,938,000USD | 5,264,000USD | 4,949,000USD | 5,119,000USD | 4,950,000USD | 4,811,000USD | 3,587,000USD |
| Total Operating Expenses | 23,764,000USD | 21,932,000USD | 22,897,000USD | 22,810,000USD | 22,171,000USD | 18,267,000USD | 18,335,000USD | 14,743,000USD |
| Operating Income | -24,430,000USD | -21,932,000USD | -22,897,000USD | -22,810,000USD | -22,171,000USD | -18,267,000USD | -18,335,000USD | -14,492,000USD |
| Interest Income | 912,000USD | 1,162,000USD | 1,372,000USD | 1,561,000USD | 1,864,000USD | 2,177,000USD | 1,846,000USD | 650,000USD |
| Net Interest Income | 912,000USD | 1,162,000USD | 1,372,000USD | 1,561,000USD | 1,864,000USD | 2,177,000USD | 1,846,000USD | 650,000USD |
| Income Before Tax | -23,516,000USD | -20,772,000USD | -21,528,000USD | -21,254,000USD | -20,311,000USD | -9,215,000USD | -17,472,000USD | -13,963,000USD |
| Net Income | -23,516,000USD | -20,772,000USD | -21,528,000USD | -21,254,000USD | -20,311,000USD | -9,215,000USD | -17,472,000USD | -13,963,000USD |
| Net Income From Continuing Ops | -23,516,000USD | -20,772,000USD | -21,528,000USD | -21,254,000USD | -20,311,000USD | -9,215,000USD | -17,472,000USD | -13,963,000USD |
| Ebit | -23,516,000USD | -20,772,000USD | -21,528,000USD | -21,254,000USD | -20,311,000USD | -9,215,000USD | -17,472,000USD | -13,963,000USD |
| Ebitda | -22,850,000USD | -20,106,000USD | -20,866,000USD | -20,613,000USD | -19,683,000USD | -8,601,000USD | -16,845,000USD | -13,376,000USD |
| Depreciation And Amortization | 666,000USD | 666,000USD | 662,000USD | 641,000USD | 628,000USD | 614,000USD | 627,000USD | 587,000USD |
| Reconciled Depreciation | 666,000USD | 666,000USD | 662,000USD | 641,000USD | 628,000USD | 614,000USD | 627,000USD | 587,000USD |
| Total Other Income Expense Net | 914,000USD | 1,160,000USD | 1,369,000USD | 1,556,000USD | 1,860,000USD | 9,052,000USD | 863,000USD | 529,000USD |
| Income Tax Expense | — | — | — | — | — | — | — | -382,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 0USD | 251,000USD | 33,492,000USD | 4,931,000USD | 0USD |
| Cost Of Revenue | 2,597,000USD | — | — | — | — |
| Gross Profit | -2,597,000USD | 251,000USD | 33,492,000USD | 4,931,000USD | — |
| Research Development | 69,540,000USD | 50,328,000USD | 50,251,000USD | 43,984,000USD | 13,845,000USD |
| Selling General Administrative | 20,270,000USD | 17,205,000USD | 13,912,000USD | 20,776,000USD | 4,426,000USD |
| Unclassified Operating Expenses | -1,797,000USD | — | — | — | — |
| Total Operating Expenses | 88,013,000USD | 67,533,000USD | 64,163,000USD | 64,760,000USD | 18,271,000USD |
| Operating Income | -90,610,000USD | -67,282,000USD | -30,671,000USD | -59,829,000USD | -18,271,000USD |
| Interest Income | 5,959,000USD | 5,349,000USD | 2,535,000USD | 1,294,000USD | 2,000USD |
| Net Interest Income | 5,959,000USD | 5,349,000USD | 2,535,000USD | 1,294,000USD | -197,000USD |
| Income Before Tax | -83,865,000USD | -58,493,000USD | -27,624,000USD | -58,335,000USD | -17,991,000USD |
| Net Income | -83,865,000USD | -58,493,000USD | -27,696,000USD | -58,388,000USD | -17,991,000USD |
| Net Income From Continuing Ops | -83,865,000USD | -58,493,000USD | -27,696,000USD | -58,388,000USD | -17,991,000USD |
| Ebit | -83,865,000USD | -58,493,000USD | -27,624,000USD | -58,335,000USD | -17,595,000USD |
| Ebitda | -81,268,000USD | -56,062,000USD | -25,358,000USD | -57,177,000USD | -17,522,000USD |
| Depreciation And Amortization | 2,597,000USD | 2,431,000USD | 2,266,000USD | 1,158,000USD | 73,000USD |
| Reconciled Depreciation | 2,597,000USD | 2,431,000USD | 2,266,000USD | 1,158,000USD | 73,000USD |
| Total Other Income Expense Net | 6,745,000USD | 8,789,000USD | 3,047,000USD | 1,494,000USD | 280,000USD |
| Tax Provision | — | 0USD | 72,000USD | 53,000USD | — |
| Income Tax Expense | — | — | 72,000USD | 53,000USD | 676,000USD |
| Interest Expense | — | — | — | — | 199,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 105,955,000USD | 130,940,000USD | 148,862,000USD | 169,391,000USD | 191,263,000USD | 209,581,000USD | 225,596,000USD | 75,912,000USD |
| Other Current Assets | 1,358,000USD | 3,891,000USD | 5,677,000USD | 6,671,000USD | 3,007,000USD | 3,057,000USD | 3,233,000USD | 1,732,000USD |
| Total Liab | 18,108,000USD | 20,970,000USD | 19,638,000USD | 20,350,000USD | 22,480,000USD | 22,940,000USD | 24,600,000USD | 267,009,000USD |
| Total Stockholder Equity | 87,847,000USD | 109,970,000USD | 129,223,999USD | 149,041,000USD | 168,783,000USD | 186,641,000USD | 200,996,000USD | -191,097,000USD |
| Other Current Liab | 5,559,000USD | 9,673,000USD | 7,099,000USD | 5,911,000USD | 6,448,000USD | 7,392,000USD | 8,344,000USD | 6,214,000USD |
| Common Stock | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | — |
| Capital Stock | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 3,000USD | 0USD |
| Retained Earnings | -354,065,000USD | -330,549,000USD | -309,777,000USD | -288,249,000USD | -266,995,000USD | -246,684,000USD | -230,589,000USD | -213,117,000USD |
| Cash | 20,955,000USD | 26,701,000USD | 25,508,000USD | 28,468,000USD | 30,401,000USD | 40,235,000USD | 55,881,000USD | 34,248,000USD |
| Cash And Short Term Investments | 86,782,000USD | 108,008,000USD | 122,968,000USD | 142,365,000USD | 165,963,000USD | 185,428,000USD | 146,631,000USD | 46,556,000USD |
| Total Current Assets | 88,740,000USD | 112,666,000USD | 129,524,000USD | 149,066,000USD | 170,004,000USD | 188,631,000USD | 150,565,000USD | 49,749,000USD |
| Total Current Liabilities | 10,880,000USD | 13,087,000USD | 11,119,000USD | 10,768,000USD | 12,204,000USD | 12,253,000USD | 13,292,000USD | 10,827,000USD |
| Net Debt | -10,692,000USD | -15,759,000USD | -13,817,000USD | -15,244,000USD | -16,405,000USD | -25,881,000USD | -40,913,000USD | -18,483,000USD |
| Short Term Debt | 3,035,000USD | 3,059,000USD | 3,172,000USD | 3,642,000USD | 3,720,000USD | 3,740,000USD | 3,733,000USD | 3,790,000USD |
| Short Long Term Debt Total | 10,263,000USD | 10,942,000USD | 11,691,000USD | 13,224,000USD | 13,996,000USD | 14,354,000USD | 14,968,000USD | 15,765,000USD |
| Short Term Investments | 65,827,000USD | 81,307,000USD | 97,460,000USD | 113,897,000USD | 135,562,000USD | 145,193,000USD | 90,750,000USD | 12,308,000USD |
| Net Receivables | 600,000USD | 767,000USD | 879,000USD | 30,000USD | 1,034,000USD | 146,000USD | 701,000USD | 1,461,000USD |
| Accounts Payable | 2,286,000USD | 355,000USD | 848,000USD | 1,215,000USD | 2,036,000USD | 1,121,000USD | 1,215,000USD | 823,000USD |
| Property Plant Equipment Net | 16,296,000USD | 17,355,000USD | 18,459,000USD | 19,826,000USD | 20,785,000USD | 20,425,000USD | 21,509,000USD | 22,735,000USD |
| Property Plant Equipment Gross | 25,402,000USD | 25,812,000USD | 26,267,000USD | 26,988,000USD | 27,319,000USD | 26,348,000USD | 26,834,000USD | 27,447,000USD |
| Accumulated Other Comprehensive Income | -18,000USD | 103,000USD | 87,000USD | 2,000USD | — | -129,000USD | 338,000USD | 121,000USD |
| Common Stock Shares Outstanding | 24,678,420shares | 24,444,057shares | 24,481,722shares | 24,378,823shares | 24,341,978shares | 24,363,119shares | 24,287,144shares | 23,281,561shares |
| Non Current Assets Total | 17,215,000USD | 18,274,000USD | 19,337,999USD | 20,325,000USD | 21,259,000USD | 20,950,000USD | 75,031,000USD | 26,163,000USD |
| Non Current Liabilities Total | 7,228,000USD | 7,883,000USD | 8,519,000USD | 9,582,000USD | 10,276,000USD | 10,687,000USD | 11,308,000USD | 256,182,000USD |
| Non Currrent Assets Other | 919,000USD | 919,000USD | 417,999USD | 499,000USD | 474,000USD | 525,000USD | 556,000USD | 3,428,000USD |
| Net Working Capital | 77,860,000USD | 99,579,000USD | 118,405,000USD | 138,298,000USD | 157,800,000USD | 176,378,000USD | 137,273,000USD | 38,922,000USD |
| Unclassified Non Current Liabilities | 7,228,000USD | 7,883,000USD | 8,519,000USD | 9,582,000USD | 10,276,000USD | 10,614,000USD | 11,235,000USD | 256,108,000USD |
| Unclassified Equity | 441,924,000USD | 440,410,000USD | 438,907,999USD | 437,282,000USD | 435,772,000USD | 433,448,000USD | 431,241,000USD | 21,899,000USD |
| Non Current Liabilities Other | — | — | — | — | — | 73,000USD | 73,000USD | 74,000USD |
| Long Term Investments | — | — | — | — | — | — | 52,966,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 130,940,000USD | 209,581,000USD | 105,114,000USD | 133,054,000USD | 169,926,000USD | 29,234,000USD | 4,839,000USD |
| Other Current Assets | 3,891,000USD | 3,057,000USD | 1,092,000USD | 1,619,000USD | 896,000USD | 666,000USD | 90,000USD |
| Total Liab | 20,970,000USD | 22,940,000USD | 267,129,000USD | 273,750,000USD | 258,784,000USD | 50,801,000USD | 8,799,000USD |
| Total Stockholder Equity | 109,970,000USD | 186,641,000USD | -162,015,000USD | -140,696,000USD | -88,858,000USD | -21,567,000USD | -3,960,000USD |
| Other Current Liab | 9,673,000USD | 7,392,000USD | 8,017,000USD | 10,152,000USD | 10,133,000USD | 3,155,000USD | 476,000USD |
| Common Stock | 3,000USD | 3,000USD | — | — | — | — | — |
| Capital Stock | 3,000USD | 3,000USD | 0USD | 0USD | 0USD | 0USD | — |
| Retained Earnings | -330,549,000USD | -246,684,000USD | -181,311,000USD | -152,591,000USD | -93,803,000USD | -21,978,000USD | -3,987,000USD |
| Cash | 26,701,000USD | 40,235,000USD | 53,504,000USD | 102,531,000USD | 160,923,000USD | 25,442,000USD | 1,872,000USD |
| Cash And Short Term Investments | 108,008,000USD | 185,428,000USD | 76,971,000USD | 102,531,000USD | 160,923,000USD | 25,442,000USD | 1,872,000USD |
| Total Current Assets | 112,666,000USD | 188,631,000USD | 79,821,000USD | 104,675,000USD | 162,287,000USD | 26,108,000USD | 1,962,000USD |
| Total Current Liabilities | 13,087,000USD | 12,253,000USD | 12,227,000USD | 25,625,000USD | 19,305,000USD | 5,764,000USD | 942,000USD |
| Net Debt | -15,759,000USD | -25,881,000USD | -36,592,000USD | -83,083,000USD | -159,182,000USD | -23,326,000USD | 5,948,000USD |
| Short Term Debt | 3,059,000USD | 3,740,000USD | 3,596,000USD | 3,486,000USD | 433,000USD | 458,000USD | 208,000USD |
| Short Long Term Debt Total | 10,942,000USD | 14,354,000USD | 16,912,000USD | 19,448,000USD | 1,741,000USD | 2,116,000USD | 7,820,000USD |
| Short Term Investments | 81,307,000USD | 145,193,000USD | 23,467,000USD | 0USD | — | — | — |
| Net Receivables | 767,000USD | 146,000USD | 1,758,000USD | 525,000USD | 468,000USD | 0USD | — |
| Accounts Payable | 355,000USD | 1,121,000USD | 614,000USD | 1,096,000USD | 1,444,000USD | 2,151,000USD | 258,000USD |
| Property Plant Equipment Net | 17,355,000USD | 20,425,000USD | 24,643,000USD | 27,617,000USD | 4,078,000USD | 2,394,000USD | 2,500,000USD |
| Property Plant Equipment Gross | 25,812,000USD | 26,348,000USD | 28,175,000USD | 28,877,000USD | 4,411,000USD | 2,478,000USD | — |
| Accumulated Other Comprehensive Income | 103,000USD | -129,000USD | 308,000USD | — | — | — | — |
| Common Stock Shares Outstanding | 24,444,057shares | 24,363,119shares | 23,281,561shares | 17,583,273shares | 17,583,273shares | 17,583,273shares | — |
| Non Current Assets Total | 18,274,000USD | 20,950,000USD | 25,293,000USD | 28,379,000USD | 7,639,000USD | 3,126,000USD | 2,877,000USD |
| Non Current Liabilities Total | 7,883,000USD | 10,687,000USD | 254,902,000USD | 248,125,000USD | 239,479,000USD | 45,037,000USD | 7,857,000USD |
| Non Currrent Assets Other | 919,000USD | 525,000USD | 650,000USD | 517,000USD | 3,561,000USD | 732,000USD | 377,000USD |
| Net Working Capital | 99,579,000USD | 176,378,000USD | 67,594,000USD | 79,050,000USD | 142,982,000USD | 20,344,000USD | — |
| Unclassified Non Current Liabilities | 7,883,000USD | 10,614,000USD | 254,829,000USD | 248,010,000USD | 239,398,000USD | 44,906,000USD | 2,213,000USD |
| Unclassified Equity | 440,410,000USD | 433,448,000USD | 18,988,000USD | 11,895,000USD | 4,945,000USD | — | — |
| Non Current Liabilities Other | — | 73,000USD | 73,000USD | 115,000USD | 81,000USD | 131,000USD | — |
| Other Assets | — | — | — | 5,000USD | — | — | — |
| Current Deferred Revenue | — | — | — | 10,891,000USD | 7,295,000USD | — | — |
| Long Term Debt | — | — | — | — | — | — | 5,644,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -23,516,000USD | -20,772,000USD | -21,528,000USD | -21,254,000USD | -20,311,000USD | -17,472,000USD | -17,843,000USD | -13,963,000USD |
| Depreciation | 666,000USD | 1,098,000USD | 305,000USD | 641,000USD | 628,000USD | 627,000USD | 603,000USD | 587,000USD |
| Stock Based Compensation | 1,593,000USD | 1,589,000USD | 1,631,000USD | 1,549,000USD | 2,052,000USD | 1,907,000USD | 1,483,000USD | 1,406,000USD |
| Other Non Cash Items | -199,000USD | 9,743,000USD | -4,506,000USD | -509,000USD | -723,000USD | 318,000USD | 2,079,000USD | -100,000USD |
| Change To Account Receivables | 67,000USD | 28,000USD | -116,000USD | 204,000USD | -88,000USD | 760,000USD | 262,000USD | 35,000USD |
| Change In Working Capital | 506,000USD | -6,384,000USD | 4,897,000USD | -3,410,000USD | -1,487,000USD | 3,009,000USD | -7,000USD | -3,016,000USD |
| Total Cash From Operating Activities | -20,950,000USD | -14,726,000USD | -19,201,000USD | -22,983,000USD | -19,841,000USD | -11,611,000USD | -13,685,000USD | -15,086,000USD |
| Capital Expenditures | -242,000USD | -421,000USD | -600,000USD | -1,055,000USD | -511,000USD | -96,000USD | -464,000USD | -18,000USD |
| Free Cash Flow | -21,192,000USD | -15,147,000USD | -19,801,000USD | -24,038,000USD | -20,352,000USD | -11,707,000USD | -14,149,000USD | -15,104,000USD |
| Investments | 15,558,000USD | 16,461,000USD | 16,278,000USD | 21,122,000USD | 9,971,000USD | -130,628,000USD | 1,349,000USD | 9,782,000USD |
| Total Cashflows From Investing Activities | 15,316,000USD | 16,040,000USD | 16,278,000USD | 21,122,000USD | 9,971,000USD | -130,628,000USD | 1,349,000USD | 9,782,000USD |
| Net Borrowings | -33,000USD | -34,000USD | -32,000USD | -33,000USD | -33,000USD | -38,000USD | — | — |
| Total Cash From Financing Activities | -112,000USD | -121,000USD | -37,000USD | -72,000USD | 239,000USD | 163,872,000USD | -1,616,000USD | 0USD |
| Change In Cash | -5,746,000USD | 1,193,000USD | -2,960,000USD | -1,933,000USD | -9,631,000USD | 21,633,000USD | -13,952,000USD | -5,304,000USD |
| Begin Period Cash Flow | 26,701,000USD | 25,969,000USD | 28,929,000USD | 30,862,000USD | 40,493,000USD | 34,506,000USD | 48,458,000USD | 53,762,000USD |
| End Period Cash Flow | 20,955,000USD | 27,162,000USD | 25,969,000USD | 28,929,000USD | 30,862,000USD | 56,139,000USD | 34,506,000USD | 48,458,000USD |
| Other Cashflows From Financing Activities | -210,000USD | -121,000USD | -37,000USD | -39,000USD | 272,000USD | -2,597,000USD | -1,538,000USD | 9,782,000USD |
| Issuance Of Capital Stock | — | 0USD | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | 1,055,000USD | — | — | — | — |
| Sale Purchase Of Stock | — | — | — | — | — | 166,507,000USD | 0USD | 0USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | — | -9,782,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|
| Net Income | -83,865,000USD | -58,788,000USD | -71,825,000USD | -17,991,000USD |
| Depreciation | 2,597,000USD | 1,158,000USD | 248,000USD | 73,000USD |
| Stock Based Compensation | 6,821,000USD | 6,584,000USD | 4,307,000USD | 297,000USD |
| Other Non Cash Items | -1,880,000USD | 4,083,000USD | 18,553,000USD | -278,000USD |
| Change To Account Receivables | 79,000USD | -57,000USD | -468,000USD | 0USD |
| Change In Working Capital | -424,000USD | -3,866,000USD | 33,413,000USD | 4,358,000USD |
| Total Cash From Operating Activities | -76,751,000USD | -50,829,000USD | -15,304,000USD | -13,541,000USD |
| Capital Expenditures | -2,587,000USD | -6,299,000USD | -1,724,000USD | -284,000USD |
| Free Cash Flow | -79,338,000USD | -57,128,000USD | -17,028,000USD | -13,825,000USD |
| Investments | 65,998,000USD | -6,299,000USD | -1,724,000USD | -284,000USD |
| Total Cashflows From Investing Activities | 63,411,000USD | -6,299,000USD | -1,724,000USD | -284,000USD |
| Net Borrowings | -132,000USD | — | 0USD | — |
| Total Cash From Financing Activities | 9,000USD | -1,264,000USD | 152,754,000USD | 37,395,000USD |
| Sale Purchase Of Stock | 0USD | -5,000USD | — | — |
| Issuance Of Capital Stock | 0USD | — | 154,612,000USD | 34,854,000USD |
| Change In Cash | -13,331,000USD | -58,392,000USD | 135,726,000USD | 23,570,000USD |
| Begin Period Cash Flow | 40,493,000USD | 161,168,000USD | 25,442,000USD | 1,872,000USD |
| End Period Cash Flow | 27,162,000USD | 102,776,000USD | 161,168,000USD | 25,442,000USD |
| Other Cashflows From Financing Activities | -230,000USD | -1,259,000USD | 152,754,000USD | 34,180,000USD |
| Unclassified Investing Cash Flow | — | 6,299,000USD | 1,724,000USD | — |
| Unclassified Financing Cash Flow | — | — | -154,612,000USD | -31,639,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.